Biochemical Engineering

Merck to build £1B London R&D hub

Merck to build £1B London R&D hub

18th August 2020

Making good on its 2017 promise to back post-Brexit Britain, US Big Pharma Merck is set to spend £1 billion ($1.31 billion) on a new unifying early research hub in England’s capital city. The new hub, which will bring together staffers from across the region to a central hub in London, will be the company's first early-stage R&D center outside of its native US. Source: Fierce Biotech 18/8/2020


Back to group news